Confido Health Secures $10M Series A to Reimagine the Phone as Healthcare’s Digital Front Door

In a moment when patient frustration and healthcare staffing challenges collide, Confido Health is raising the stakes in AI-powered access. The New York–based startup has secured a $10 million Series A round, led by Blume Ventures with participation from Schema Ventures, Vicus Ventures, and prior backers Together Fund, DeVC, and Medmountain Ventures—bringing its total capital to $13 million.

Confido is deploying its new capital to expand its voice-AI platform beyond basic scheduling tasks—towards a system that can answer, resolve, and document patient calls in a single interaction. In doing so, it aims to turn the phone (still the most common patient touchpoint) into a far more efficient, empathetic, and integrated entry point into care.

Reinventing the Phone Tree

Despite the rise of digital portals and chatbots, many patients still pick up the phone. Data shows that a large majority of patients begin by calling their provider, triggering old annoyances: long hold times, complex menu trees, missed callbacks, or staff overload.

Confido’s pitch: dismantle the outdated phone tree altogether. Its system answers on the first ring, authenticates the caller, checks insurance eligibility, and resolves the patient’s intent—whether that’s booking an appointment, getting a refill, checking status, initiating a referral or intake, or managing payments. Every interaction is written back into the EHR or practice management system, while complex cases are smoothly transferred to staff when human judgment is required.

The aim is “one and done”—less call-backs, less friction, and better alignment between patient demand and provider workflows. In markets where fewer than half of calls are resolved on the first try, Confido is positioning itself to push that figure significantly higher.

Over the past eight months, the company reports a tenfold expansion in reach: it now handles inbound and outbound access for more than one million patients, up from 150,000 at the end of 2024.

What Makes Confido Stand Out in a Crowded Field

The healthcare voice-AI space is becoming increasingly competitive. Many vendors begin with scheduling and gradually layer on customer service. Confido’s differentiation lies in its ambition to handle a wider spectrum of “access” workflows from the outset—refills, payments, referrals, reactivation, and even care coordination.

Automation success rates above 80 percent, supported by deep EHR and phone-system integrations, allow patients to get what they need without bouncing to another system. For multi-site practices and private-equity-backed groups, that coherence in experience helps scale operations, unify patient touchpoints, and reduce overhead.

One customer example is Dallas Renal Group. With Confido, about two-thirds of outbound calls now result in instant appointment confirmations, and fewer than six percent must be forwarded to staff. On inbound calls, wait times have dropped to roughly 15 seconds—saving staff nearly 50 hours in a single week.

With this infusion of capital, Confido’s roadmap becomes more ambitious. Beyond scheduling, its next expansion areas include recall and reactivation workflows, integrated payments, complex care coordination, analytics, audit trails, and first-call resolution metrics. Specialty-specific playbooks tailored to fields like nephrology, dermatology, GI, pediatrics, orthopedics, and pain medicine are also on the horizon.

Confido sees itself as building the infrastructure layer for patient communication, especially in a world of consolidating healthcare platforms and multisite operations. It wants to be the “standard layer” over which clinic groups can scale and unify patient access.

The Broader Significance: What This Means for Healthcare’s Future

The release of this funding is not just a company milestone; it signals a deeper shift in how healthcare access might evolve in the coming years. Because Confido is tackling a seemingly mundane but structurally critical interface—the phone—it offers a lens into where AI can have real impact beyond hype.

Most current voice-AI systems remain reactive: someone calls, the system answers. The next frontier is anticipating needs, triggering outbound reactivation, or guiding patients before they even pick up the phone. Confido’s roadmap already includes pushing into recalls and reactivation workflows, hinting at this shift.

Another key factor is integration. Many AI pilots stall because of weak connectivity with legacy EHRs, phone systems, and workflows. Confido is betting that the real defensibility lies not in its chat model, but in the plumbing behind it: seamless data flow, auditability, context retention, and escalation logic. That means the future winners in healthcare AI will likely be those who can coordinate systems, not just models.

At the same time, a purely machine-driven future remains unlikely. One strength in Confido’s narrative is that it frames itself not as replacing humans, but as alleviating their load. The complexity of healthcare conversations, clinical nuance, and emotional context means that AI still will have to partner with human judgment, especially for edge cases. The better the handoff logic, the more trusted the system becomes.

This trajectory also places new pressure on legacy vendors that historically treated the front desk as just another module. The “phone as digital front door” can no longer be an afterthought. As practices increasingly demand unified platforms, older systems may struggle unless they evolve or form partnerships.

Finally, if voice-AI systems like Confido’s scale widely, patients may see fewer barriers in booking, refills, or referral navigation. Quicker and more consistent access could mean earlier interventions, fewer no-shows, and better continuity of care. For underserved communities where digital literacy or portal usage lags, a reliable phone-based AI assistant—a medium more familiar to many—may even act as a powerful equalizer.